April 5, 2016
Diplomat’s Taltz approved for treatment of plaque psoriasis
TALTZ was recently approved by the U.S. Food and Drug Administration to treat adults with moderate-to-severe plaque psoriasis.
Pharmaceuticals, Biotechnology and Life Sciences
TALTZ was recently approved by the U.S. Food and Drug Administration to treat adults with moderate-to-severe plaque psoriasis.